11 March 2010, 9:23 am
BRISBANE, Australia, March 11 /PRNewswire/ -- Australian drug development company CBio Limited (ASX: CBZ) today announced the achievement of a clinical trial milestone under its option agreement with global pharmaceutical leader Novo Nordisk A/S.... Read More »